With A Reported ~$3B Invested In HealthTech In 2016, Asia Currently Ranks Number Two Globally! https://t.co/SdsltyfMVK — The Propell Group (@ThePropellGroup) February 16, 2017 #healthtech
Global Healthcare | 21 Deals, Investments & Transactions | Week 6 – Feb 2017 https://t.co/XVeMsftD1t — The Propell Group (@ThePropellGroup) February 16, 2017 #healthtech
Cancer experts urge greater focus on prevention | The Japan Times https://t.co/BWkm0RW51P — The Propell Group (@ThePropellGroup) February 16, 2017 #healthtech
Tsinghua’s Venture Arm Leads $18M Round In Cancer Diagnosis Start-Up – China Money Network https://t.co/Yha2rPOqov — The Propell Group (@ThePropellGroup) February 16, 2017 #healthtech
China’s Fosun Co-Leads $16M Round In Pharmacy Mobile App Yaoshibang – China Money Network https://t.co/FArrspEJw3 — The Propell Group (@ThePropellGroup) February 16, 2017 #healthtech
This billionaire’s cancer moonshot is falling far short of the hype https://t.co/PKaDr7a4HQ — The Propell Group (@ThePropellGroup) February 16, 2017 #healthtech
Faster set-up, fewer hurdles for venture capitalists, Companies & Markets News & Top Stories – The Straits Times https://t.co/Hnqx0ZR3Ya — The Propell Group (@ThePropellGroup) [...]
With A Reported ~$3B Invested In HealthTech In 2016, Asia Currently Ranks Number Two Globally! https://t.co/3HzmDBLayx — The Propell Group (@ThePropellGroup) February 16, 2017 #healthtech
“The Case for a HealthTech Regulatory Sandbox in Singapore” https://t.co/XUBhGeWnvf by @ThePropellGroup on @LinkedIn — The Propell Group (@ThePropellGroup) February 16, 2017 #healthtech
Asia HealthTech CEO Summit 2016 Report is now available! – Galen Growth Asia https://t.co/wrisimHcAo — The Propell Group (@ThePropellGroup) February 15, 2017 #healthtech